These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

474 related articles for article (PubMed ID: 36532071)

  • 21. Nano-sized drug delivery systems to potentiate the immune checkpoint blockade therapy.
    Shim MK; Song SK; Jeon SI; Hwang KY; Kim K
    Expert Opin Drug Deliv; 2022 Jun; 19(6):641-652. PubMed ID: 35603410
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nanomicelle protects the immune activation effects of Paclitaxel and sensitizes tumors to anti-PD-1 Immunotherapy.
    Yang Q; Shi G; Chen X; Lin Y; Cheng L; Jiang Q; Yan X; Jiang M; Li Y; Zhang H; Wang H; Wang Y; Wang Q; Zhang Y; Liu Y; Su X; Dai L; Tang M; Li J; Zhang L; Qian Z; Yu D; Deng H
    Theranostics; 2020; 10(18):8382-8399. PubMed ID: 32724476
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nanocarrier-Mediated Immunogenic Cell Death for Melanoma Treatment.
    Wang J; Ma J; Tai Z; Li L; Zhang T; Cheng T; Yu J; Zhu Q; Bao L; Chen Z
    Int J Nanomedicine; 2023; 18():7149-7172. PubMed ID: 38059000
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunogenic cell death-related risk signature predicts prognosis and characterizes the tumour microenvironment in lower-grade glioma.
    Cai J; Hu Y; Ye Z; Ye L; Gao L; Wang Y; Sun Q; Tong S; Yang J; Chen Q
    Front Immunol; 2022; 13():1011757. PubMed ID: 36325335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A bio-responsive, cargo-catchable gel for postsurgical tumor treatment via ICD-based immunotherapy.
    Chen Q; Zhou S; Ding Y; Chen D; Dahiru NS; Tang H; Xu H; Ji M; Wang X; Li Z; Chen Q; Li Y; Tu J; Sun C
    J Control Release; 2022 Jun; 346():212-225. PubMed ID: 35461965
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radiation-Induced Immunogenic Cell Death for Cancer Radioimmunotherapy.
    Liu T; Pei P; Shen W; Hu L; Yang K
    Small Methods; 2023 May; 7(5):e2201401. PubMed ID: 36811166
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiotherapy, immunotherapy, and the tumour microenvironment: Turning an immunosuppressive milieu into a therapeutic opportunity.
    Donlon NE; Power R; Hayes C; Reynolds JV; Lysaght J
    Cancer Lett; 2021 Apr; 502():84-96. PubMed ID: 33450360
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhancing TNBC Chemo-immunotherapy via combination reprogramming tumor immune microenvironment with Immunogenic Cell Death.
    Wu S; Liu D; Li W; Song B; Chen C; Chen D; Hu H
    Int J Pharm; 2021 Apr; 598():120333. PubMed ID: 33540008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeted Nanophotoimmunotherapy Potentiates Cancer Treatment by Enhancing Tumor Immunogenicity and Improving the Immunosuppressive Tumor Microenvironment.
    Li K; Yang D; Liu D
    Bioconjug Chem; 2023 Feb; 34(2):283-301. PubMed ID: 36648963
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Promotion of ICD via Nanotechnology.
    Qin Y; Zhang H; Li Y; Xie T; Yan S; Wang J; Qu J; Ouyang F; Lv S; Guo Z; Wei H; Yu CY
    Macromol Biosci; 2023 Sep; 23(9):e2300093. PubMed ID: 37114599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunogenic cell death related risk model to delineate ferroptosis pathway and predict immunotherapy response of patients with GBM.
    Feng S; Liang X; Li J; Wang Z; Zhang H; Dai Z; Luo P; Liu Z; Zhang J; Xiao X; Cheng Q
    Front Immunol; 2022; 13():992855. PubMed ID: 36248827
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Zoledronic Acid-Gadolinium Coordination Polymer Nanorods for Improved Tumor Radioimmunotherapy by Synergetically Inducing Immunogenic Cell Death and Reprogramming the Immunosuppressive Microenvironment.
    Huang Z; Yao D; Ye Q; Jiang H; Gu R; Ji C; Wu J; Hu Y; Yuan A
    ACS Nano; 2021 May; 15(5):8450-8465. PubMed ID: 33938751
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Redox-Activated Porphyrin-Based Liposome Remote-Loaded with Indoleamine 2,3-Dioxygenase (IDO) Inhibitor for Synergistic Photoimmunotherapy through Induction of Immunogenic Cell Death and Blockage of IDO Pathway.
    Liu D; Chen B; Mo Y; Wang Z; Qi T; Zhang Q; Wang Y
    Nano Lett; 2019 Oct; 19(10):6964-6976. PubMed ID: 31518149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor Microenvironment-Activatable Prodrug Vesicles for Nanoenabled Cancer Chemoimmunotherapy Combining Immunogenic Cell Death Induction and CD47 Blockade.
    Zhou F; Feng B; Yu H; Wang D; Wang T; Ma Y; Wang S; Li Y
    Adv Mater; 2019 Apr; 31(14):e1805888. PubMed ID: 30762908
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immune-regulating bimetallic metal-organic framework nanoparticles designed for cancer immunotherapy.
    Dai Z; Wang Q; Tang J; Wu M; Li H; Yang Y; Zhen X; Yu C
    Biomaterials; 2022 Jan; 280():121261. PubMed ID: 34815099
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent progress in stimuli-responsive nanosystems for inducing immunogenic cell death.
    Banstola A; Poudel K; Kim JO; Jeong JH; Yook S
    J Control Release; 2021 Sep; 337():505-520. PubMed ID: 34314800
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prodrug-Based Versatile Nanomedicine for Enhancing Cancer Immunotherapy by Increasing Immunogenic Cell Death.
    Bai S; Yang LL; Wang Y; Zhang T; Fu L; Yang S; Wan S; Wang S; Jia D; Li B; Xue P; Kang Y; Sun ZJ; Xu Z
    Small; 2020 May; 16(19):e2000214. PubMed ID: 32309900
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular determinants of immunogenic cell death elicited by radiation therapy.
    Galassi C; Klapp V; Yamazaki T; Galluzzi L
    Immunol Rev; 2024 Jan; 321(1):20-32. PubMed ID: 37679959
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiation-Induced Transformation of Immunoregulatory Networks in the Tumor Stroma.
    Martinez-Zubiaurre I; Chalmers AJ; Hellevik T
    Front Immunol; 2018; 9():1679. PubMed ID: 30105016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor matrix remodeling and novel immunotherapies: the promise of matrix-derived immune biomarkers.
    Mushtaq MU; Papadas A; Pagenkopf A; Flietner E; Morrow Z; Chaudhary SG; Asimakopoulos F
    J Immunother Cancer; 2018 Jul; 6(1):65. PubMed ID: 29970158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.